One quarter into the new fiscal year, more than a dozen Vanderbilt technologies have been awarded patent protection by the USPTO. The four newest, which were issued throughout the month of September, include:
Over the past several years, we’ve observed shifting times within the biotech and pharmaceutical industry, as companies try to determine the best way to fill both their pipelines and revenue streams while approaching and recovering from the patent cliff.
For Byron Smith, his graduate-level research was personal. After losing his father to cancer, he was eager to explore ways to make colonoscopy less dreaded and increase the number of people who get screened for Colorectal Cancer each year. As his collaborator and former professor Pietro Valdastri quickly pointed out, early screening is key to saving lives.
REDCap, a prospective Vanderbilt startup based on a comprehensive electronic data capture (EDC) solution, is one of just five new ventures selected to compete in this year's Life Science TN Venture Pitch Forum.
Four new patents protecting Vanderbilt intellectual property were assigned during the month of August. The technologies represent fields such as neuroscience, cellular biology, molecular biology, cancer therapy, and diagnostics.
Five Vanderbilt inventions received patent protection from the USPTO in July. The technologies represent a variety of fields, including cell biology, molecular biology, cancer therapy, neuroscience, and vaccine production, among others.
Some powerful work is going on behind the walls of Vanderbilt Children's Hospital Outpatient Center. The Center embarked on a 100-Day Workout to identify ways they could improve internal processes.
InvisionHeart CEO Josh Nickols, PhD, had entrepreneurs and investors talking after pitching his smart ECG-based company at JumpStart Foundry’s DEMO Day.
